1. Home
  2. AMST vs ADXN Comparison

AMST vs ADXN Comparison

Compare AMST & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$1.00

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$6.05

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
ADXN
Founded
2017
2002
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.6M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
AMST
ADXN
Price
$1.00
$6.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
86.4K
3.3K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
N/A
EPS
N/A
N/A
Revenue
$110,459.00
N/A
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$5.41
52 Week High
$4.78
$12.05

Technical Indicators

Market Signals
Indicator
AMST
ADXN
Relative Strength Index (RSI) 40.06 46.59
Support Level $0.88 $5.75
Resistance Level $2.12 $7.37
Average True Range (ATR) 0.10 0.36
MACD -0.01 0.02
Stochastic Oscillator 10.26 37.08

Price Performance

Historical Comparison
AMST
ADXN

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: